Pfizer Unveils Mammoth $11B Buyback Program
Pharmaceutical titan Pfizer Inc. said Thursday it would redirect its cash stores into an eye-popping $11 billion share buyback program after its attempt at a blockbuster merger with British rival AstraZeneca...To view the full article, register now.
Already a subscriber? Click here to view full article